Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 82 citing Baffis: Use of interferon for prevention of hepatocellular carcinoma in cirrhotic patients.... (0.10 sec) 

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 …

- oncozuidwest.be [PDF] 
J Bruix, M Sherman, JM Llovet, M Beaugrand, … - Journal of hepatology, 2001 - Elsevier
Hepatocellular carcinoma (HCC) is a neoplasm the incidence of which is
increasing worldwide, but striking geographical differences are observed for
both risk factors and occurrence [1]. HCC represents more than 5% of all ...
Cited by 1109 - Related articles - BL Direct - All 9 versions

Viral hepatitis C

- temple.edu [PDF] 
T Poynard, MF Yuen, V Ratzin, CL Lai - The Lancet, 2003 - Elsevier
More than 170 million people worldwide are chronically infected with the
hepatitis C virus (HCV), which is responsible for more than 100 000 cases of
liver cancer per year, with similar numbers of digestive haemorrhage and ...
Cited by 375 - Related articles - All 11 versions

Interferon and prevention of hepatocellular carcinoma in viral cirrhosis: an evidence-based …


C Cammā, M Giunta, P Andreone, A Craxė - Journal of Hepatology, 2001 - Elsevier
Methods: Three randomized controlled trials and 15 nonrandomized controlled
trials, including 4614 patients and comparing IFN to no treatment, were
selected. Data on the incidence of HCC in IFN treated and untreated ...
Cited by 220 - Related articles - BL Direct - All 5 versions

Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B …


BJ McMahon, P Holck, L Bulkow, M Snowball - Annals of internal medicine, 2001 - Am Coll Physicians
Objective: To determine the incidence of and risk factors for adverse events
(hepatocellular carcinoma and end-stage liver disease) and clearance of
hepatitis B e antigen (HBeAg) and surface antigen (HBsAg) in carriers of HBV.
Cited by 202 - Related articles - All 9 versions

Neoadjuvant and adjuvant therapy for resectable hepatocellular carcinoma: review of the …


JD Schwartz, M Schwartz, J Mandeli, M Sung - The Lancet Oncology, 2002 - Elsevier
Hepatocellular carcinoma (HCC) is common worldwide, and its incidence is
increasing. Liver resection or transplantation is potentially curative, although
subsequent recurrence and death are common. We reviewed randomised trials ...
Cited by 123 - Related articles - All 9 versions

Transcriptional suppression of matrix metalloproteinase-9 gene expression by IFN-{gamma} …

- jimmunol.org
Z Ma, H Qin, EN Benveniste - The Journal of Immunology, 2001 - Am Assoc Immnol
Matrix metalloproteinases (MMPs) are a family of zinc-dependent endopeptidases
that play crucial roles in proteolytic degradation of the extracellular matrix.
Aberrant expression of the 92-kDa type IV collagenase (MMP-9) is implicated ...
Cited by 95 - Related articles - BL Direct - All 3 versions

Phase II trial of systemic continuous fluorouracil and subcutaneous recombinant interferon …

- ascopubs.org
YZ Patt, MM Hassan, RD Lozano, TD Brown, JN … - Journal of Clinical Oncology, 2003 - jco.ascopubs.org
Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
From the Department of Gastrointestinal Medical Oncology and Digestive ...
Cited by 79 - Related articles - BL Direct - All 8 versions

Prevention of hepatitis C virus–related hepatocellular carcinoma


EJ Heathcote - Gastroenterology, 2004 - Elsevier
The incidence of hepatocellular carcinoma (HCC) is increasing in North America,
Europe, and Japan, caused largely by the high rates of chronic hepatitis C virus
(HCV) infection. In such individuals, the risk factors for developing HCC ...
Cited by 66 - Related articles - BL Direct - All 16 versions

Hepatitis C virus viremia in HIV-infected individuals with negative HCV antibody tests


SL George, J Gebhardt, D Klinzman, MB Foster … - JAIDS Journal of Acquired Immune Deficiency …, 2002 - journals.lww.com
Summary: Hepatitis C virus (HCV) viremia may occur in persons without detectable
HCV antibodies and has been reported in as many as 5.5% of HIV-positive persons.
To better characterize serosilent HCV infection, the authors prospectively ...
Cited by 66 - Related articles - BL Direct - All 5 versions

Rising prevalence of hepatitis C virus infection among patients recently diagnosed with …


MM Hassan, A Frome, YZ Patt, HB El-Serag - Journal of clinical gastroenterology, 2002 - journals.lww.com
Hepatocellular carcinoma (HCC) often develops in pa- tients with liver cirrhosis
caused by hepatitis C virus (HCV), hepatitis B virus (HBV), or excessive alcohol
con- sumption.1–4 A recently published report suggests that the incidence ...
Cited by 59 - Related articles - BL Direct - All 6 versions


Result Page: 

1

2

3

4

5

6

7

8

9

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google